Propanediol monoacetate mononitrate
AssigneeDsm IP Assets B.V.
InventorsChristine Mendrok-Edinger, Peter Riebel, Angela Wildermann
Life of this patent
Estimating the term…
Abstract
The present invention relates to propanediol monoacetate mononitrate as well as the use thereof as antimicrobial agent, in particular for cosmetic applications.
Claims18
Propanediol monoacetate mononitrate of formula (I)
A method to improve preservation of a product by inhibiting microbial degradation thereof, wherein the method comprises adding an anti-microbial effective amount of 1,3-propanediol monoacetate mononitrate to the product.
A method to maintain skin homeostasis and/or balance skin microbiome which comprises contacting the skin with an effective amount of 1,3-propanediol monoacetate mononitrate.
A deodorant product which comprises 1,3-propanediol monoacetate mononitrate as a deodorant active compound.
An anti-acne product which comprises 1,3-propanediol monoacetate mononitrate as an anti-acne agent.
A method for treating skin conditions selected from the group consisting of Pityriasis versicolor, dandruff formation, seborrheic dermatitis, atopic dermatitis and psoriasis, wherein the method comprises applying to skin in need thereof an effective treatment amount of 1,3-propanediol monoacetate mononitrate.
A cosmetic or pharmaceutical composition comprising 1,3-propanediol monoacetate mononitrate.
A non-therapeutic method for killing and/or inhibiting growth of microbial cells, wherein the method comprises contacting the microbial cells with an effective amount of 1,3-propanediol monoacetate mononitrate.
A process for preparing 1,3-propanediol monoacetate mononitrate, wherein the process comprises reacting 1,3-propandiol monoacetate with nitrosulfuric acid.
Dependencies are inferred from the claim text.